Your browser doesn't support javascript.
loading
Survival of patients with mucosal melanoma in Cali, Colombia: a retrospective cohort study.
García, Ana M; Parra-Lara, Luis G; Mendoza-Urbano, Diana M; Bravo, Juan C; Zambrano Harvey, Ángela.
Afiliação
  • García AM; Hematology and Clinical Oncology Service, Department of Internal Medicine, Fundación Valle del Lili, Cra. 98 Nro.18 -49, 760032, Cali, Colombia.
  • Parra-Lara LG; Centro de Investigaciones Clínicas (CIC), Fundación Valle del Lili, Cali, Colombia.
  • Mendoza-Urbano DM; Facultad de Ciencias de La Salud, Universidad Icesi, Cali, Colombia.
  • Bravo JC; Centro de Investigaciones Clínicas (CIC), Fundación Valle del Lili, Cali, Colombia.
  • Zambrano Harvey Á; Departament of Pathology and Clinical Laboratory, Fundación Valle del Lili, Cali, Colombia.
BMC Cancer ; 24(1): 886, 2024 Jul 23.
Article em En | MEDLINE | ID: mdl-39044133
ABSTRACT

BACKGROUND:

Mucosa melanoma is a rare condition with aggressive behavior and a less favorable prognosis compared to cutaneous melanoma. The objective of this study was to estimate the overall survival and clinical outcomes of patients diagnosed with mucosal melanoma in a Colombian hospital.

METHODS:

A retrospective cohort study was conducted at Fundación Valle del Lili, a single center located in Cali, Colombia. Patients aged ≥ 18 years, both sexes, diagnosed with mucosal melanoma by histopathology study were included between 2010-2019. Patients who received extra-institutional treatment or whose vital status was unknown during follow-up were excluded. Demographic, clinical and laboratory data were obtained from medical records and laboratory and pathology databases. A descriptive analysis was performed. Survival analysis was conducted using the Kaplan-Meier method.

RESULTS:

A total of 23 patients were included. Median age was 63 years old (IQR 57-68) and 52.2% were woman. Clinical stage was 34.8% early, 26.1% locally advanced and 39.1% metastatic. The main primary locations were nasopharynx (30.4%), genitals (26.1%), rectum (21.7%), oral cavity (13%) and paranasal sinuses (8.7%). The majority received surgery (30.4%) and immunotherapy (26.1%) as first line treatment. Overall survival at one year was 80.8%, at three years 44.3%, and at five years 36.9%.

CONCLUSION:

Mucosal melanoma is a rare, aggressive disease with adverse oncological outcomes due to late diagnosis and limited treatment options. This study provides real-world data in a single-center of Colombia.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma / Mucosa Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Colombia Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma / Mucosa Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Colombia Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Reino Unido